Literature DB >> 14725763

Remote phosphate contacts trigger assembly of the active site of DNA topoisomerase IB.

Ligeng Tian1, Christopher D Claeboe, Sidney M Hecht, Stewart Shuman.   

Abstract

Vaccinia topoisomerase IB forms a covalent DNA-(3'-phosphotyrosyl)-enzyme intermediate at its target site 5'-CCCTTp downward arrow in duplex DNA. The contributions of backbone electrostatics and individual phosphate oxygens to the transesterification reaction were probed by introducing 22 single Rp and Sp methylphosphonate diastereomers at 11 positions flanking the cleavage site. Methyl groups at eight positions (four on the scissile strand and four on the nonscissile strand) inhibited the rate of single-turnover cleavage by factors of 50-50,000. Stereospecific interference was observed at several phosphates, thereby distinguishing simple electrostatic contributions from putative specific polar contacts to either the pro-Sp or pro-Rp oxygens. The functionally relevant phosphate oxygens are located on the minor groove face of the helix on which the scissile phosphodiester resides. Our findings, combined with available crystal structures of vaccinia and human topoisomerase IB, show how specific phosphate contacts remote from where chemistry occurs are critical for assembly of the active site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725763     DOI: 10.1016/j.str.2003.11.025

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  12 in total

Review 1.  Cellular strategies for regulating DNA supercoiling: a single-molecule perspective.

Authors:  Daniel A Koster; Aurélien Crut; Stewart Shuman; Mary-Ann Bjornsti; Nynke H Dekker
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

Review 2.  Probing enzyme phosphoester interactions by combining mutagenesis and chemical modification of phosphate ester oxygens.

Authors:  James T Stivers; Rajesh Nagarajan
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

3.  Major groove interactions of vaccinia Topo I provide specificity by optimally positioning the covalent phosphotyrosine linkage.

Authors:  Rajesh Nagarajan; James T Stivers
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

4.  Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.

Authors:  Lyudmila Yakovleva; Shengxi Chen; Sidney M Hecht; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

5.  Crystal structure of a bacterial topoisomerase IB in complex with DNA reveals a secondary DNA binding site.

Authors:  Asmita Patel; Lyudmila Yakovleva; Stewart Shuman; Alfonso Mondragón
Journal:  Structure       Date:  2010-06-09       Impact factor: 5.006

6.  Arylstibonic acids: novel inhibitors and activators of human topoisomerase IB.

Authors:  Hyeongnam Kim; John H Cardellina; Rhone Akee; James J Champoux; James T Stivers
Journal:  Bioorg Chem       Date:  2008-05-27       Impact factor: 5.275

7.  Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB.

Authors:  Benjamin Reed; Lyudmila Yakovleva; Stewart Shuman; Ranajeet Ghose
Journal:  Biochemistry       Date:  2017-06-19       Impact factor: 3.162

8.  The open state of human topoisomerase I as probed by molecular dynamics simulation.

Authors:  Giovanni Chillemi; Alessandro Bruselles; Paola Fiorani; Susana Bueno; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

9.  Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation.

Authors:  Levent Sari; Ioan Andricioaei
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

Review 10.  Structural studies of type I topoisomerases.

Authors:  Nicole M Baker; Rakhi Rajan; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.